EcoDrugPlus

Erb-B2 Receptor Tyrosine Kinase 2

Ensembl ID : ENSCPOG00000005777
Gene Symbol: ERBB2
2 Cross references
200 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSCPOG00000014852
Gene Symbol: ERBB3
4 Cross references
280 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSCPOG00000011232
Gene Symbol: ERBB4
2 Cross references
320 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSCPOG00000008317
Gene Symbol: ESR1
4 Cross references
212 Possible Orthologues:

Estrogen Receptor 2

Ensembl ID : ENSCPOG00000005703
Gene Symbol: ESR2
2 Cross references
274 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSCPOG00000036099
Gene Symbol: ESRRG
4 Cross references
206 Possible Orthologues:

Exportin 1

Ensembl ID : ENSCPOG00000034053
Gene Symbol: XPO1
2 Cross references
296 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSCPOG00000015363
Gene Symbol: FDPS
2 Cross references
268 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSCPOG00000007700
Gene Symbol: FDFT1
4 Cross references
218 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSCPOG00000000249
Gene Symbol: FNTA
2 Cross references
221 Possible Orthologues:

Farnesyltransferase, Caax Box, Beta

Ensembl ID : ENSCPOG00000015285
Gene Symbol: FNTB
2 Cross references
211 Possible Orthologues:

Fatty Acid Amide Hydrolase

Ensembl ID : ENSCPOG00000011399
Gene Symbol: FAAH
2 Cross references
131 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).